Full-Time
Posted on 8/14/2026
Develops and markets food safety tests
No salary listed
Lincoln, NE, USA
In Person
Associate's
See people who can refer or advise you
Neogen develops and markets test kits and services to detect a range of safety issues in the food and animal supply chain. Its products help identify foodborne bacteria, natural toxins, and drug residues in animals, and the company divides its offerings into two segments: Food Safety and Animal Safety. Products are delivered as test kits and related services that enable customers to screen and verify safety at various stages from farm to fork. The firm differentiates itself through its scale and geographic reach, a consequence of the 2022 merger with 3M’s food safety business that nearly doubled its size and created a global leader in food safety by expanding product lines and geographic footprint. Neogen’s goal is to ensure the safety of the world’s food supply by providing comprehensive tools and services that detect contaminants and residues across the food and animal industries.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Lansing, Michigan
Founded
1982
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Flexible Work Hours
Remote Work Options
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Hybrid Work Options
Stock Options
Company Equity
401(k) Retirement Plan
401(k) Company Match
Performance Bonus
Profit Sharing
Employee Stock Purchase Plan
Relocation Assistance
Employee Referral Bonus
Student Loan Assistance
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Childcare Support
Elder Care Support
Pet Insurance
Bereavement Leave
Professional Development Budget
Conference Attendance Budget
Training Programs
Tuition Reimbursement
Professional Certification Support
Mentorship Program
Wellness Program
Mental Health Support
Gym Membership
Commuter Benefits
Meal Benefits
Phone/Internet Stipend
Home Office Stipend
Legal Services
Employee Discounts
Company Social Events
Glenmede Trust Co. NA reduces position in Neogen Corporation $NEOG. August 2, 2026 Key points. * Glenmede Trust reduced its Neogen position by 7.3% in the first quarter, selling 144,411 shares and retaining 1.83 million shares valued at approximately $17 million. Institutional investors collectively own 96.73% of the company. * Neogen exceeded fiscal fourth-quarter expectations with adjusted EPS of $0.09 and revenue of $225.3 million, while management forecast fiscal 2027 revenue of $880 million-$885 million and adjusted EBITDA of $180 million-$182 million. * Despite the earnings beat and upbeat outlook, revenue was nearly flat year over year, analysts maintain a consensus "Hold" rating with a $10.67 price target, and planned 50% higher R&D spending could pressure near-term margins. * Interested in Neogen? Here are five stocks we like better. Glenmede Trust Co. NA decreased its holdings in Neogen Corporation (NASDAQ:NEOG - Free Report) by 7.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,829,298 shares of the company's stock after selling 144,411 shares during the period. Glenmede Trust Co. NA owned approximately 0.84% of Neogen worth $16,994,000 at the end of the most recent quarter. A number of other institutional investors have also bought and sold shares of the business. Cibc World Markets Corp purchased a new stake in shares of Neogen in the fourth quarter valued at approximately $47,983,000. T. Rowe Price Investment Management Inc. increased its holdings in shares of Neogen by 249.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,181,768 shares of the company's stock valued at $57,191,000 after purchasing an additional 5,838,570 shares during the last quarter. SG Americas Securities LLC lifted its position in Neogen by 287.4% during the first quarter. SG Americas Securities LLC now owns 6,266,033 shares of the company's stock worth $58,211,000 after buying an additional 4,648,436 shares in the last quarter. Bank of Montreal Can lifted its position in Neogen by 4,059.4% during the third quarter. Bank of Montreal Can now owns 4,592,218 shares of the company's stock worth $26,222,000 after buying an additional 4,481,812 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its stake in Neogen by 250.2% during the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,490,800 shares of the company's stock worth $24,401,000 after buying an additional 2,493,900 shares during the last quarter. 96.73% of the stock is owned by hedge funds and other institutional investors. Key headlines impacting Neogen. Here are the key news stories impacting Neogen this week: * Positive Sentiment: Neogen reported fiscal Q4 adjusted earnings of $0.09 per share, above the $0.05 analyst consensus and substantially better than the $2.82-per-share loss reported in the year-ago quarter. Revenue of $225.3 million also exceeded estimates of $212.35 million. Neogen Beats Q4 Earnings and Revenue Estimates * Positive Sentiment: Management forecast fiscal 2027 revenue of $880 million to $885 million, above the $851.1 million consensus estimate. First-quarter fiscal 2027 revenue guidance of $207 million to $209 million also topped the $204.9 million consensus. Neogen Fiscal 2027 Guidance * Positive Sentiment: The company expects fiscal 2027 adjusted EBITDA of approximately $180 million to $182 million, signaling anticipated improvement in profitability and supporting the favorable investor reaction. Neogen Fiscal 2026 Results * Neutral Sentiment: Despite the earnings beat, quarterly revenue was essentially flat year over year, down 0.1%, indicating that the stronger outlook depends on future growth rather than current top-line acceleration. * Neutral Sentiment: Analysts' average price target is approximately $10.67, below the stock's recent trading level, suggesting valuation and expectations may limit additional upside. Analysts Set Neogen Price Target * Negative Sentiment: Neogen plans to increase research and development spending by roughly 50% in fiscal 2027. Although intended to support longer-term growth, the investment could pressure near-term margins and earnings. Neogen stock performance. NASDAQ:NEOG opened at $12.04 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.84 and a current ratio of 3.82. The stock has a market capitalization of $2.62 billion, a P/E ratio of -401.33, a PEG ratio of 5.39 and a beta of 1.80. The company has a 50 day moving average price of $9.44 and a 200 day moving average price of $9.62. Neogen Corporation has a fifty-two week low of $4.56 and a fifty-two week high of $12.15. Discover more Stock Screener Tool Financial News Subscription Neogen (NASDAQ:NEOG - Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported $0.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.03. Neogen had a positive return on equity of 2.78% and a negative net margin of 0.91%.The company had revenue of $225.30 million for the quarter, compared to analyst estimates of $212.35 million. During the same quarter in the previous year, the company earned ($2.82) earnings per share. The firm's quarterly revenue was down .1% compared to the same quarter last year. Equities research analysts forecast that Neogen Corporation will post 0.22 EPS for the current year. Analysts Set new price targets. Several brokerages have issued reports on NEOG. Wall Street Zen upgraded Neogen from a "hold" rating to a "buy" rating in a report on Saturday, May 9th. Weiss Ratings lowered Neogen from a "sell (d-)" rating to a "sell (e+)" rating in a report on Friday, July 24th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $10.67. Neogen company profile. Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user-friendly assays to food processors, grain handlers and quality laboratories around the world. In the food safety arena, Neogen's product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E. Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Corporation (NASDAQ:NEOG - Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Neogen, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neogen wasn't on the list. While Neogen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you'll find 7 stocks that could play a major role in the next tech-driven market boom.
Neogen reported a fiscal Q4 net loss of $11.3 million on revenue of $225.3 million and posted a full-year loss of $7.9 million on revenue of $870.4 million. Despite remaining unprofitable, the company sharply reduced losses year-over-year whilst boosting core revenue growth. For fiscal 2027, Neogen issued revenue guidance of $880 million to $885 million. Management plans to increase R&D and transformation spending, partly funded through a planned sale of its Genomics business and debt repayment. The company faces ongoing risks including integration challenges from its 3M acquisition, securities litigation, and recent product quality issues. Neogen is not expected to achieve profitability in the next few years. Community fair value estimates for the stock range widely from roughly $13 to above $33 per share.
Neogen reported second-quarter revenue of $225.3 million, flat year on year but beating analyst estimates by 6%. The life sciences company's non-GAAP profit of $0.09 per share exceeded consensus by 58.8%. The company provided full-year revenue guidance of $882.5 million at the midpoint, 3.9% above analyst estimates. EBITDA guidance for financial year 2027 came in at $181 million, also exceeding expectations. Despite the strong quarter, Neogen's recent performance shows a decline from its five-year trend, with revenue falling at an annualised rate of 3% over the past two years. Analysts project revenue will continue declining by 3.2% over the next 12 months. Operating margin improved to 1.4%, up from negative 271% in the same quarter last year.
Why 24/7 support is essential to automated poultry production. Hear from Vincent Fevrier, Vice President of Sales and Marketing for EMEAO at TARGAN. In an industry where every minute counts, the future is increasingly being shaped by real-time insight, predictive support, and automation that never sleeps. As poultry producers worldwide replace manual processes with intelligent systems, pairing advanced technology with a resilient, responsive service model is essential to unlocking their full value. The real value of automated solutions goes beyond installing machines. Building an ecosystem where global support and data-driven decision-making work in synchronicity across time zones is what keeps hatcheries running at peak performance while minimizing downtime. Around the clock support TARGAN's approach has always been rooted in the principle that technology only matters if it performs flawlessly in the real world. This model begins with a distributed team of technicians and engineers located in the US, Europe, and Asia, all connected through a unified monitoring platform. This team oversees every installation, analyzing live data streams and maintaining constant contact with local field teams. TARGAN's hybrid service structure - the 24/7 support network - blends remote expertise with on-site response, offering hatcheries a safety net that operates around the clock, whether the customer is based in Peru, Poland, or Pennsylvania. Stories from the Hatchery Several examples show how this model works in practice, and the value offered by TARGAN's partnerships that run parallel with the technology itself. One hatchery in Italy recently experiences the benefits of TARGAN's proactive monitoring before their production day had even begun. "We arrived in the morning for production - it was 6am. Before we started, we got a call telling us to do some setting change because the machine was not ready. As soon as we did that, the machine worked perfectly during the day. That was amazing." A similar situation unfolded in Spain, where remote monitoring detected an issue before hatchery staff even stepped through the door. As Vincent explains: "Our remote team saw that there was a power jump in the hatchery. On Monday morning, when the hatchery workers arrived, they were surprised to see local technicians arriving at the same time to resolve the issue. They could start production on time." These examples underscore the value of TARGAN's 24/7 support network and serve as a reminder that automation alone isn't enough. What matters is automation supported by a global, proactive service model that prevents downtime before it begins. Data as the foundation for performance WingScan, TARGAN's automated chick sexing system, is supported by a suite of dashboards and monitoring tools designed for both hatchery managers and TARGAN's support network team. Hatchery managers can access production data via desktop or mobile app, including throughput, sexing results, and daily performance. Remote technicians see deeper machine-level diagnostics. "They will see the motor amps, they will see the temperature, they will see the speed of a belt, and they can detect if the quality of the chicks is not ideal for the performance of a machine." This dual-layer visibility enables TARGAN to link machine performance directly to chick quality and incubation outcomes. It's a shift from reactive troubleshooting to predictive optimization, helping hatcheries to understand now just what happened, but also why it happened. In an industry where small variations can have large downstream effects, this level of insight is becoming indispensable. The growth of automation The adoption curve for automation is steepening. TARGAN introduced WingScan at the end of 2023, and demand continues to scale. As Vincent explains: "This year we're going to more than double the number of systems installed in Europe. We are installing mainly in Italy, Spain, Poland, and France." These are markets where sexing is already widely practiced, and hatcheries are readily transitioning from manual to automated processes. "For hatcheries, the benefit is to address labor challenges, increase the quality of sexing, and address welfare issues." WingScan's growth reflects the industry's movement toward a model where reliability is engineered, support is continuous, and performance is predictable. Within this landscape, TARGAN's combination of innovation, global monitoring, and proactive service is setting a new benchmark for what modern hatchery automation can deliver. You may also like... * Revolutionary, Non-Invasive In-Ovo Sexing Technology Makes History As First In United States In a groundbreaking development forthe United Statesegg industry, anIowahatchery has become the first site to offer an automatedin-ovo sex determining solution in the nation. * New Technology Could Prevent The Mass Cull Of Male Chicks A staggering 6.5 billion chicks are killed worldwide every year. These are generally male chicks that are of no economic value. In Ovo has developed technology that can quickly determine the sex of a... * Canada, Ontario Supporting Innovation For Ontario's Chicken Farmers The governments of Canada and Ontario are helping farmers and other businesses in the province's broiler chicken egg and hatcheries sector enhance traceability of its products. * Neogen Launches Chlorinated Tray Wash EVO Neogen announced today that it has added Chlorinated Tray Wash EVO to its line of phosphate-free and biodegradable cleaners for a wide variety of agricultural applications. * TARGAN And VETIPLUS Partner To Accelerate Advanced Automation In Colombia's Poultry Industry TARGAN, a global leader in automation and technology solutions for the animal protein industry, today announced a distribution partnership with Colombian animal health company, VETIPLUS. * TARGAN And Wayne-Sanderson Farms Announce Expansion Of Commercial Collaboration * NestFresh Welcomes The First In-Ovo Sexed Flock In The U.S., Marking A Historic Milestone In Animal Welfare * Miller Poultry Contracts Natureform For New Hatchery Renovation In Indiana * Optimal Chick Storage Conditions With Petersime's New BioStreamer Chick-Store * Cobb-Brazil Live Haul Trailers Deliver Climate Control * Cobb Europe Completes UK Hatchery Expansion * Smart From The Outset: Pioneering On A Steep Learning Curve In Namibia
UQ research sharpens new genetic test to breed polled cattle. Australian cattle producers can more accurately determine whether Bos indicus animals in their herd will grow horns, thanks to a new genetic test developed using University of Queensland research. UQ's commercialisation company UniQuest licensed the research to Neogen Corporation, which unveiled its new genetic test at the Australian Brahman Breeders' Association annual conference in Airlie Beach. Queensland Alliance for Agriculture and Food Innovation Associate Professor Elizabeth Ross said her team identified a previously undetected variant of the polled, or hornless, gene in Australian cattle. "The Guarani poll test is a specialised genetic test used in cattle breeding to identify the presence of a specific hornless genetic variant in Bos indicus breeds, such as the Australian Brahman," Dr Ross said. "This is the first test able to detect a Guarani poll mutation, which is one of 4 gene variants associated with hornless cattle including Celtic, Friesian and Mongolian." Dr Ross said existing commercial genetic tests detected only 2 of the 4 known hornless or polled mutations. "Cattle producers are increasingly using DNA tests to breed horns out of their cattle herds because polled animals are safer and allow for more welfare-friendly management," Dr Ross said. "Seedstockcentral know the Pg allele, the variant gene causing horns not to grow on some animals, is out there in the Australian Brahman population because Seedstockcentral has found it directly in 3 of the 4 herds Seedstockcentral studied. "This test will finally give producers with hornless cattle more accurate genetic test results and allow them to purposely breed hornless calves." Neogen strategic beef accounts manager Hannah Bourke said it was pleased to partner with UniQuest to deliver the new Guarani Poll DNA test to the Australian market. "We are proud to be able to deliver commercially relevant solutions to industry," Ms Bourke said. UniQuest CEO Dr Dean Moss said it was exciting to see UQ research drive meaningful results for Australian producers. "This test will give Australian cattle producers confidence in their breeding decisions and it's fantastic UQ research has played a vital role in that," Dr Moss said. The test will be available to Australian producers from May 2026. The Poll Guarani allele was originally discovered by Utsunomiya et al in 2019 in cattle in Brazil, and named as Guarani (PG) after the aquifer beneath its assumed region of origin. -University of Queensland